Evidence map›Paper›PMID 23018179›Full record

ArticleExperimental cell research2013

Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.

Ogan D Abaan, Wiljan Hendriks, Aykut Uren, Jeffrey A Toretsky, Hayriye V Erkizan

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Inhibitors of the AAA+ chaperone p97.Molecules (Basel, Switzerland) · 2015
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ogan D AbaanDepartments of Oncology and Pediatrics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA. oda@georgetown.edu
Wiljan Hendriks
Aykut Uren
Jeffrey A Toretsky
Hayriye V Erkizan
Georgetown University · USRadboud University Nijmegen · NL

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
TRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8M
Signaling Pathways that Determine Ewings Sarcoma OutcomeR01CA088004 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI TORETSKY, JEFFREY A · 2001 to 2008
$1.7M
NCI NIH HHS P30 CA051008NCI NIH HHS P30CA051008NCI NIH HHS R01 CA088004NCI NIH HHS T32 CA009686Wellcome Trust
6 · The paper itself

Abstract

Identification of Protein Tyrosine Phosphatase (PTP) substrates is critical in understanding cellular role in normal cells as well as cancer cells. We have previously shown that reduction of PTPL1 protein levels in Ewings sarcoma (ES) inhibit cell growth and tumorigenesis. Therefore, we sought to identify novel PTPL1 substrates that may be important for tumorigenesis. In this current work, we demonstrated that mouse embryonic fibroblasts without PTPL1 catalytic activity fail to form foci when transfected with oncogenes. We proved that catalytic activity of PTPL1 is important for ES cell growth. Using a substrate-trapping mutant of PTPL1 we identified putative PTPL1 substrates by mass-spectrometry. One of these putative substrates was characterized as Valosin Containing Protein (VCP/p97). Using multiple biochemical assays we validated VCP as a novel substrate of PTPL1. We also provide evidence that tyrosine phosphorylation of VCP might be important for its midbody localization during cytokinesis. In conclusion, our work identifies VCP as a new substrate for PTPL1, which may be important in cellular transformation. Our investigation link an oncogenic transcription factor EWS-FLI1, with a key transcriptional target protein tyrosine phosphatase PTPL1, and its substrate VCP. Given our observation that PTPL1 catalytic activity is important for cell transformation, our results may also suggest that VCP regulation by PTPL1 might be important for tumorigenesis.

Indexed as

Adenosine TriphosphatasesAnimalsBone NeoplasmsCatalysisCell Cycle ProteinsCell Line, TumorCells, CulturedCell Transformation, NeoplasticFibroblastsHEK293 CellsHumansMiceMice, Mutant StrainsPancreatic NeoplasmsProtein Tyrosine Phosphatase, Non-Receptor Type 13Sarcoma, EwingAdenosine TriphosphatasesCell Cycle ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 13Ptpn13 protein, mouseValosin Containing ProteinVCP protein, humanVcp protein, mouse

Identifiers

PMID23018179
PMCPMC3638858
OpenAlexW2087075661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.